Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alx Oncology Holdings (ALXO) Shares Issued (2020 - 2023)

Alx Oncology Holdings' Shares Issued history spans 4 years, with the latest figure at $411000.0 for Q4 2023.

  • For Q4 2023, Shares Issued rose 1108.82% year-over-year to $411000.0; the TTM value through Dec 2023 reached $219000.0, down 34.82%, while the annual FY2025 figure was $14000.0, 99.95% down from the prior year.
  • Shares Issued for Q4 2023 was $411000.0 at Alx Oncology Holdings, up from -$226000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $195.5 million in Q4 2020 and bottomed at -$675000.0 in Q2 2021.
  • The 4-year median for Shares Issued is $298000.0 (2022), against an average of $19.9 million.
  • The largest annual shift saw Shares Issued plummeted 99.73% in 2021 before it soared 1108.82% in 2023.
  • A 4-year view of Shares Issued shows it stood at $195.5 million in 2020, then tumbled by 99.73% to $529000.0 in 2021, then plummeted by 93.57% to $34000.0 in 2022, then skyrocketed by 1108.82% to $411000.0 in 2023.
  • Per Business Quant, the three most recent readings for ALXO's Shares Issued are $411000.0 (Q4 2023), -$226000.0 (Q3 2023), and $34000.0 (Q4 2022).